Teva Ajovy Injection and Austedo, new data
23 abstracts appeared in the 2020 American Academy of Neurology (AAN) Science Highlights Supplement TEL AVIV & PARSIPPANY, N.J.–(BUSINESS WIRE)–Teva…
Pharmaceuticals, Biotechnology and Life Sciences
23 abstracts appeared in the 2020 American Academy of Neurology (AAN) Science Highlights Supplement TEL AVIV & PARSIPPANY, N.J.–(BUSINESS WIRE)–Teva…
If approved, Kalydeco (ivacaftor) will be the first and only medicine in Europe to treat the underlying cause of cystic fibrosis in patients with the R117H mutation, the most common residual function mutation, as young as 6 months of age.
– If approved, the combination has the potential to be the first targeted regimen specifically for patients with BRAFV600E-mutant metastatic…
Entered into an exclusive collaboration and license agreement with Apollomics for development and commercialization of uproleselan and GMI-1687 in the…
U.S. FDA set target action date of September 3, 2020 Application based on results from the Phase 3 QUAZAR®-AML-001 study…
Pivotal SORAYA Trial Initiated for Mirvetuximab Soravtansine in Platinum-Resistant Ovarian Cancer Data from FORWARD II Avastin® Expansion Cohort in Platinum-Agnostic…
University Hospitals Cleveland Medical Center, a nationally ranked hospital, is ready to start screening patients CLEVELAND–(BUSINESS WIRE)–$ATHX #ARDS–Athersys, Inc. (NASDAQ:…
Certain people need to take additional energy in the form of specific supplements, but they are not a substitute for a balanced healthy diet.
Medidata praised for its people-centric approach, and diverse and inclusive culture LONDON–(BUSINESS WIRE)–Medidata, the global leader in creating end-to-end solutions…
SOMERSET, N.J.–(BUSINESS WIRE)–Catalent, Inc. (NYSE: CTLT), the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs,…